+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Disposable Endoscopes Market Size, Share & Trends Analysis Report by Application (Bronchoscopy, Urologic Endoscopy, Arthroscopy, GI Endoscopy, ENT Endoscopy), by End Use, by Country, and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 150 Pages
  • April 2022
  • Region: Europe
  • Grand View Research
  • ID: 5595820
The Europe disposable endoscopes market size is expected to reach USD 1.8 billion by 2030. It is expected to expand at a CAGR of 16.9% from 2022 to 2030. The increasing cases of cross-contamination complications due to the use of reusable endoscopes are driving the adoption of single-use endoscopic devices. In addition, the growing number of chronic and respiratory diseases in Europe and the shortage of medical staff for cleaning and disinfecting reusable endoscopes in between the surgical procedures drive the market for disposable endoscopes. For instance, a study published in the European Respiratory journal in 2021 stated that about 36.6 million Europeans are having COPD and the number will be increased to 49.5 million by 2050. Furthermore, the risk associated with reusable endoscopes such as clogging, leakage, and the chance of contamination due to the tedious sterilization process is further expected to boost the market growth during the forecast period.



The bronchoscopy application segment dominated the market and held a revenue share of over 25.0% in 2021. Bronchoscopy is a common procedure used to remove blockages and foreign bodies from the lungs or airways. However, reusable endoscopes are the potential source of disease transmission. While the disposable bronchoscope could decrease the risk of cross-contamination, increase safety and efficiency, and can be used with limited resources. In addition, increasing recommendations by most respiratory societies to use disposable bronchoscopes during the SARS-CoV-2 pandemic is accelerating the growth of the segment. Moreover, the ENT endoscopy segment is expected to witness the fastest growth during the forecast period owing to the high preference for the use of disposable endoscopic devices to limit the chances of infection during the ear, nose, and throat diagnostic procedures.

The hospitals end-use segment dominated the market with a revenue share of over 45.0% in 2021. This is attributed to the increasing patient preference for hospitals to diagnose and treat their chronic diseases. In addition, favorable reimbursement policies and low-cost surgical procedures provided by the government hospitals are expected to boost the segment growth. Moreover, the increasing adoption of disposable endoscopic devices and the growing number of private and government hospitals with endoscopic procedure facilities are supporting the growth of the segment. The clinics segment is anticipated to expand at the fastest CAGR during the forecast period owing to the increasing adoption of single-use endoscopes in clinics for better patient engagement with low cross-contamination chances, quick recovery time, and lower post-procedural complications.

Furthermore, the rapid rise of COVID-19 cases in Europe has limited the number of surgical procedures. However, due to the benefits of disposable endoscopes such as lower chances of cross-contamination, time efficiency, safety, short hospital stay, and lower post-procedure infections, many endoscopic procedure facilities have increasingly adopted the single-use endoscopic devices during the COVID-19 pandemic, which favored the growth of the market in 2020. The shortage of clinical personnel due to the viral infections and government-imposed lockdown and shutdowns further decreased the use of conventional endoscopes and in turn, increased the adoption of disposable endoscopic devices, thereby propelling the market growth during the COVID-19 pandemic.

Europe Disposable Endoscopes Market Report Highlights

  • The market growth in Europe can be attributed to the growing number of chronic and respiratory diseases, the shortage of medical staff, and the increasing adoption of single-use endoscopic devices in healthcare institutions in the region.
  • Based on application, the bronchoscopy segment dominated the market with a revenue share of over 25.0% in 2021 owing to the increasing adoption of single-use bronchoscopes due to their lower risk of cross-contamination and increased safety and efficiency.
  • Based on end use, the hospitals segment dominated the market with a revenue share of over 45.0% in 2021 owing to the increasing adoption of disposable endoscopic devices and the growing number of private and government hospitals with endoscopic procedure facilities.


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1 Market Segmentation and Scope
1.2 Market Definition
1.3 Research Methodology
1.3.1 Information Procurement
1.3.1.1 Purchased database:
1.3.1.2 internal database
1.3.2 Primary Research:
1.4 Research Scope and Assumptions
1.5 List to Data Sources
Chapter 2. Executive Summary
2.1 Europe Disposable Endoscopes Market Outlook
2.2 Europe Disposable Endoscopes Market Segment Outlook
2.3 Europe Disposable Endoscopes Market Competitive Insight
2.4 Europe Disposable Endoscopes Snapshot
Chapter 3. Europe Disposable Endoscopes Market Variables, Trends, & Scope
3.1 Disposable Endoscopes Market Snapshot
3.2 Penetration and Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.2 Market Restraint Analysis
3.3.3 Industry Challenges
3.4 Europe Disposable Endoscopes Market Analysis Tools
3.4.1 Industry Analysis-Porter’s
3.4.1.1 Bargaining power of the suppliers
3.4.1.2 Bargaining power of the buyers
3.4.1.3 Threats of substitution
3.4.1.4 Threats from new entrants
3.4.1.5 Competitive rivalry
3.4.2 PESTEL Analysis
3.4.2.1 Political landscape
3.4.2.2 Economic and Social landscape
3.4.2.3 Technology landscape
3.4.2.4 Legal landscape
3.4.2.5 Technology landscape
3.5 Major Deals & Strategic Alliances Analysis
3.5.1 Mergers & Acquisitions
3.5.2 Technology Collaborations
3.5.3 Joint Ventures
Chapter 4. Europe Disposable Endoscopes Market: Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company/Competition Categorization (Key innovators, market leaders, emerging players)
4.3 Vendor Landscape
4.3.1 Public Companies
4.3.1.1 Company Market Position Analysis
4.3.1.2 Company Market Ranking, by Region
4.3.2 Private Companies
4.3.2.1 Regional network map
4.3.2.2 Company market position analysis
Chapter 5. Europe Disposable Endoscopes Market: Application Estimates & Trend Analysis
5.1 Definitions & Scope
5.2 Europe Disposable Endoscopes Market: Application Market Share Analysis, 2021 and 2030
5.3 Bronchoscopy
5.3.1 Bronchoscopy market estimates and forecasts, 2014-2030 (USD million)
5.4 Urologic Endoscopy
5.4.1 Urologic Endoscopy market estimates and forecasts, 2014-2030 (USD million)
5.5 Arthroscopy
5.5.1 Arthroscopy market estimates and forecasts, 2014-2030 (USD million)
5.6 GI Endoscopy
5.6.1 GI Endoscopy market estimates and forecasts, 2014-2030 (USD million)
5.7 ENT Endoscopy
5.7.1 ENT Endoscopy market estimates and forecasts, 2014-2030 (USD million)
5.8 Others
5.8.1 Others market estimates and forecasts, 2014-2030 (USD million)
Chapter 6. Europe Disposable Endoscopes Market: End-use Estimates & Trend Analysis
6.1 Definitions & Scope
6.2 Europe Disposable Endoscopes Market: End-use Market Share Analysis
6.3 Hospitals
6.3.1 Hospitals market estimates and forecasts, 2014-2030 (USD million)
6.4 Clinics
6.4.1 Clinics market estimates and forecasts, 2014-2030 (USD million)
6.5 Diagnosis Centers
6.5.1 Diagnosis Centers market estimates and forecasts, 2014-2030 (USD million)
Chapter 7. Europe Disposable Endoscopes Market: Country Estimates & Trend Analysis, by Application, by End Use
7.1 Europe
7.1.1 Europe Disposable Endoscopes market estimates and forecasts, by Application, and, End use, 2014-2030 (USD million)
7.1.2 U.K.
7.1.2.1 U.K. Disposable Endoscopes market estimates and forecasts, by Application, and, End use, 2014-2030 (USD million)
7.1.3 Germany
7.1.3.1 Germany Disposable Endoscopes market estimates and forecasts, by Application, and, End use, 2014-2030 (USD million)
7.1.4 France
7.1.4.1 France Disposable Endoscopes market estimates and forecasts, by Application, and, End use, 2014-2030 (USD million)
7.1.5 Italy
7.1.5.1 Italy Disposable Endoscopes market estimates and forecasts, by Application, and, End use, 2014-2030 (USD million)
7.1.6 Spain
7.1.6.1 Spain Disposable Endoscopes market estimates and forecasts, by Application, and, End use, 2014-2030 (USD million)
7.1.7 Russia
7.1.7.1 Russia Disposable Endoscopes market estimates and forecasts, by Application, and, End use, 2014-2030 (USD million)
7.1.8 Denmark
7.1.8.1 Market estimates and forecasts, by Application, and, End use, 2014-2030 (USD Million)
7.1.9 Switzerland
7.1.9.1 Market estimates and forecasts, by Application, and, End use, 2014-2030 (USD Million)
Chapter 8. Competitive Landscape
8.1 Ambu A/S
8.1.1 Company overview
8.1.2 Financial performance
8.1.3 Product benchmarking
8.1.4 Strategic initiatives
8.2 Prosurg Inc. (Neoscape, Inc.)
8.2.1 Company overview
8.2.2 Financial performance
8.2.3 Product benchmarking
8.2.4 Strategic initiatives
8.3 AirStrip Technologies
8.3.1 Company overview
8.3.2 Financial performance
8.3.3 Product benchmarking
8.3.4 Strategic initiatives
8.4 Boston Scientific Corporation
8.4.1 Company overview
8.4.2 Financial performance
8.4.3 Product benchmarking
8.4.4 Strategic initiatives
8.5 Parburch Medical
8.5.1 Company overview
8.5.2 Financial performance
8.5.3 Product benchmarking
8.5.4 Strategic initiatives
8.6 OBP Medical Corporation
8.6.1 Company overview
8.6.2 Financial performance
8.6.4 Product benchmarking
8.6.4 Strategic initiatives
8.7 Welch Allyn (Hill-Rom Services Inc.)
8.7.1 Company overview
8.7.2 Financial performance
8.7.3 Product benchmarking
8.7.4 Strategic initiatives
8.8 Allscripts Healthcare Solutions
8.8.1 Company overview
8.8.2 Financial performance
8.8.3 Product benchmarking
8.8.4 Strategic initiatives
8.9 Flexicare Medical Limited
8.9.1 Company overview
8.9.2 Financial performance
8.9.3 Product benchmarking
8.9.4 Strategic initiatives
8.10 Timesco Healthcare Ltd.
8.10.1 Company overview
8.10.2 Financial performance
8.10.3 Product benchmarking
8.10.4 Strategic initiatives
8.11 SUNMED
8.11.1 Company overview
8.11.2 Financial performance
8.11.3 Product benchmarking
8.11.4 Strategic initiatives

Companies Mentioned

  • Ambu A/S
  • Prosurg Inc. (Neoscape, Inc.)
  • Airstrip Technologies
  • Boston Scientific Corporation
  • Parburch Medical
  • Obp Medical Corporation
  • Welch Allyn (Hill-Rom Services Inc.)
  • Allscripts Healthcare Solutions
  • Flexicare Medical Limited
  • Timesco Healthcare Ltd.
  • Sunmed

Methodology

Loading
LOADING...

Table Information